HCA · News · 20261112N

Securities Fraud Investigation

HCA Healthcare, Inc. · 2026-11-12 · Importance 28 · Surprise 42

Pomerantz LLP is investigating HCA Healthcare and certain executives over alleged securities fraud or unlawful business practices. The investigation follows HCA’s July 2026 reduction of its full-year profit forecast, which the reports attribute to an unfavorable payer-mix shift. One report said the payer mix reduced second-quarter 2026 revenue by approximately $400 million and that HCA’s stock fell nearly 7%; the reported revenue impact is below the materiality threshold.

Key facts